SINGAPORE (Aug 17): TPG Capital Asia, the Asian investment platform of global alternative asset firm TPG, has today completed its acquisition of Quest Laboratories, a Singapore-based medical laboratory.

This acquisition is a part of TPG’s A$279 million ($279 million) purchase of Healthscope Limited’s Asian pathology laboratories that operate under the brand “Quest Laboratories” in Singapore and Vietnam, as well as “Gribbles Pathology” in Malaysia.

Quest Laboratories is a full-service private laboratory, which is to be dually accredited by the College of American Pathologists and the Singapore Accreditation Council. It also serves specialist doctors, general practitioners, as well as integrated healthcare providers with a full suite of laboratory tests.

Quest Laboratories’ main laboratory in Singapore spans over 25,000 sq ft and has the largest fully automated sample management system in Singapore. . Its satellite laboratories located in Paragon Medical, Thomson Medical Centre and Novena Medical service the key private hospitals, medical centres and specialist clinics.

In Vietnam, Quest Laboratories operates two laboratories in Ho Chi Minh City in a women’s and children’s private hospital and in the central urban district.

Richard Seow, TPG Senior Advisor and incoming Chairman of Quest Laboratories says, “The healthcare sector is one of TPG’s key investment areas and we look forward to leveraging Quest’s core competencies to grow our pathology business across Southeast Asia.”